A two-year field trial in China's Turpan-Hami Basin shows that a redesigned Double-Layer Curtain canopy system, especially ...
Unrivalled ESG leadership: Klépierre’s strategy and best-in-class performance were once again recognized in 2026 by the Global Real Estate Sustainability Benchmark (GRESB). Since 2024, the Group has ...
Global insured losses from natural catastrophes reached US$92 billion during the first nine months of 2026, 29% below the ...
AstraZeneca and Amgen reported Phase III CROSSING data showing that Tezspire (tezepelumab) improved histologic remission and ...
Suppose you are asked in a Toray interview, 'Why do you want to join Toray?' and you answer, 'Because you developed the world ...
Germany is the European Union’s (EU) largest pharmaceutical market by revenue and has the highest medical biotechnology ...
Le Thi Huong Giang, class DDP0702, is the valedictorian of the International Training Institute, Academy of Finance in 2026 ...
Positive results from the CLARITY-Gastric01 global Phase III trial showed AstraZeneca’s sonesitatug vedotin (Sone-Ve) demonstrated a statistically significant and highly clinically meaningful ...
1dOpinion
Weekly Commentary: Need To Talk
South Korea's tech-heavy KOSPI dropped 2.8% Thursday, with Samsung down 4% and SK Hynix sinking 5.5%. Read more here.
Statistically Significant Total Endoscopic Remission with No Visible Inflammation or Fibrosis Attained Versus Placebo at Week 52 THOUSAND OAKS, Calif., Oct. 20, 2026 // -- Amgen (NASDAQ:AMGN) and ...
First and only biologic therapy to achieve statistically significant and clinically meaningful histologic remission and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results